Barr Receives Approval For Generic XANAX XR(R) Tablets

... Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market ageneric version of Pfizer Inc.'s XANAX XR(R) (Alprazolam Extended-Release)Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch itsproduct immediately. [click link for full article] ...